Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in Chinese population and potential targets for clinical practice
Author(s) -
Xue Liang,
Chao Guo,
Kang Zhang,
Hang Jiang,
Fei Pang,
Ying Dou,
Xiaoyan Liu,
Hanqing Lin,
Xiaowei Dong,
Songhui Zhao,
Ming Yao,
Kai Wang,
Yujie Feng,
Weiguang Gu
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.08.05
Subject(s) - cdkn2a , kras , medicine , arid1a , cohort , oncology , population , targeted therapy , cancer research , mapk/erk pathway , chinese population , bioinformatics , gene , mutation , genotype , cancer , genetics , biology , kinase , colorectal cancer , environmental health
Cholangiocarcinoma (CCA) is a diverse group of malignancies arising from the intra- or extrahepatic biliary epithelium and characterized by its late diagnosis and fatal outcome. Extrahepatic cholangiocarcinoma (ECC) accounts for 90% of CCA. However, little is known about the comprehensive genomic alterations of ECC in Chinese population for providing clinical managements especially targeted therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom